Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032
Overview
The Europe Induced Pluripotent Stem Cells (iPSCs) Market is expected to reach a 648.05 USD Million by 2032 and is projected to grow at a CAGR of 11.00% from 2025 to 2032.
Revenue, 2024 (USD Million)
333.63
Forecast, 2032 (USD Million)
648.05
CAGR, 2024 - 2032
11.00%
Report Coverage
Europe
Europe Induced Pluripotent Stem Cells (iPSCs) Market 2018-2032 USD Million
Europe Induced Pluripotent Stem Cells (iPSCs) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 333.63 USD Million
- Projected Market Size (2032): 648.05 USD Million
- CAGR (2025-2032): 11.00%
Key Findings of Europe Induced Pluripotent Stem Cells (iPSCs) Market
- The Europe Induced Pluripotent Stem Cells (iPSCs) Market was valued at 333.63 USD Million in 2024.
- The Europe Induced Pluripotent Stem Cells (iPSCs) Market is likely to grow at a CAGR of 11.00% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Human iPSCs in Type Segment accounted for the largest share of the market with a revenue of 235.24 USD Million
- The fastest growing segment Biotechnology & Pharmaceutical Companies in End User Segment grew Fastest with a CAGR of 13.56% during the forecast period from 2024 to 2032.
Europe Induced Pluripotent Stem Cells (iPSCs) Market Scope
Europe Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope
Cell Source
- Blood Cells
- Skin Cells
Type
- Mouse iPSCs
- Human iPSCs
Product
- Instruments
- Services
- Consumables & Kits
Application
- Others
- 3D Bioprinting
- Stem Cell Banking
- Toxicology Screening
- Regenerative Medicine
- Cellular Therapy
- Disease Modelling
- Academic Research
- Drug Discovery And Development
End User
- Others
- Diagnostic Laboratories
- Research Laboratories
- Biotechnology & Pharmaceutical Companies
Distribution Channel
- Retail Sales
- Direct Tender
Europe Induced Pluripotent Stem Cells (iPSCs) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 333.63 USD Million |
| Market Value in 2032 | 648.05 USD Million |
| CAGR (2025-2032) | 11.00% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Cell Source,Type,Product,Application,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 333.63 USD Million in 2024
- Key Country: Germany, leading in terms of revenue with value of 98.32 USD Million in 2024.
Segments and Scope
-
Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Cell Source
- Skin Cells is the largest segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 216.08 USD Million in the year 2024.
- Skin Cells is the Fastest growing segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 11.22 % in forecast period 2025-2032.
-
Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Type
- Human iPSCs is the largest segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 235.24 USD Million in the year 2024.
- Human iPSCs is the Fastest growing segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 11.84 % in forecast period 2025-2032.
-
Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Product
- Consumables & Kits is the largest segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 171.69 USD Million in the year 2024.
- Consumables & Kits is the Fastest growing segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 12.15 % in forecast period 2025-2032.
-
Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Application
- Drug Discovery And Development is the largest segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 76.40 USD Million in the year 2024.
- Academic Research is the Fastest growing segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 11.77 % in forecast period 2025-2032.
-
Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By End User
- Biotechnology & Pharmaceutical Companies is the largest segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 166.32 USD Million in the year 2024.
- Biotechnology & Pharmaceutical Companies is the Fastest growing segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 13.56 % in forecast period 2025-2032.
-
Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 221.58 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 12.12 % in forecast period 2025-2032.
Europe Induced Pluripotent Stem Cells (iPSCs) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Lonza | |||
| Thermo Fisher Scientific Inc. | |||
| Evotec SE | |||
| FUJIFILM Corporation | |||
Europe Induced Pluripotent Stem Cells (iPSCs) Market Geographical Sales Distribution, 2018-2032 USD Million
Europe Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Cell Source,Type,Product,Application,End User,Distribution Channel.
Europe Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 333.63(Revenue in USD Million) in 2022.
Europe Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 11.00% during the forecast period of 2024 to 2032.
The Human iPSCs segment is expected to dominate the Europe Induced Pluripotent Stem Cells (iPSCs) Market, holding a largest market share of 235.24 USD Million in 2024
Europe Induced Pluripotent Stem Cells (iPSCs) Market Scope
Europe Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope
Cell Source
- Blood Cells
- Skin Cells
Type
- Mouse iPSCs
- Human iPSCs
Product
- Instruments
- Services
- Consumables & Kits
Application
- Others
- 3D Bioprinting
- Stem Cell Banking
- Toxicology Screening
- Regenerative Medicine
- Cellular Therapy
- Disease Modelling
- Academic Research
- Drug Discovery And Development
End User
- Others
- Diagnostic Laboratories
- Research Laboratories
- Biotechnology & Pharmaceutical Companies
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Europe Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Cell Source,Type,Product,Application,End User,Distribution Channel.
Europe Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 333.63(Revenue in USD Million) in 2022.
Europe Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 11.00% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Induced Pluripotent Stem Cells (iPSCs) Market for final year is USD 648.05 (USD Million).
Europe Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Frequently Asked Questions
The Europe Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Cell Source,Type,Product,Application,End User,Distribution Channel.
Europe Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 333.63(Revenue in USD Million) in 2022.
Europe Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 11.00% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Induced Pluripotent Stem Cells (iPSCs) Market for final year is USD 648.05 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.